New Delhi’s All India Institute of Medical Sciences is one of the 17 sites selected to conduct Phase II/III, observer-blind, randomized, controlled study, to check the safety and immune response of ...
New Delhi’s All India Institute of Medical Sciences is one of the 17 sites selected to conduct Phase II/III, observer-blind, randomized, controlled study, to check the safety and immune response of ...